JP2003522797A5 - - Google Patents

Download PDF

Info

Publication number
JP2003522797A5
JP2003522797A5 JP2001559478A JP2001559478A JP2003522797A5 JP 2003522797 A5 JP2003522797 A5 JP 2003522797A5 JP 2001559478 A JP2001559478 A JP 2001559478A JP 2001559478 A JP2001559478 A JP 2001559478A JP 2003522797 A5 JP2003522797 A5 JP 2003522797A5
Authority
JP
Japan
Prior art keywords
och
micelle
patient
aqueous solution
branched
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001559478A
Other languages
English (en)
Japanese (ja)
Other versions
JP4959085B2 (ja
JP2003522797A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/005297 external-priority patent/WO2001060382A1/en
Publication of JP2003522797A publication Critical patent/JP2003522797A/ja
Publication of JP2003522797A5 publication Critical patent/JP2003522797A5/ja
Application granted granted Critical
Publication of JP4959085B2 publication Critical patent/JP4959085B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2001559478A 2000-02-18 2001-02-20 ミセル Expired - Lifetime JP4959085B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18376800P 2000-02-18 2000-02-18
US60/183,768 2000-02-18
PCT/US2001/005297 WO2001060382A1 (en) 2000-02-18 2001-02-20 Micelles

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012025659A Division JP2012116860A (ja) 2000-02-18 2012-02-09 ミセル

Publications (3)

Publication Number Publication Date
JP2003522797A JP2003522797A (ja) 2003-07-29
JP2003522797A5 true JP2003522797A5 (https=) 2011-11-04
JP4959085B2 JP4959085B2 (ja) 2012-06-20

Family

ID=22674206

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001559478A Expired - Lifetime JP4959085B2 (ja) 2000-02-18 2001-02-20 ミセル
JP2012025659A Pending JP2012116860A (ja) 2000-02-18 2012-02-09 ミセル

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012025659A Pending JP2012116860A (ja) 2000-02-18 2012-02-09 ミセル

Country Status (10)

Country Link
US (3) US6906042B2 (https=)
EP (2) EP2452684B1 (https=)
JP (2) JP4959085B2 (https=)
KR (1) KR100841813B1 (https=)
AU (2) AU2001238507C9 (https=)
CA (1) CA2400371C (https=)
ES (1) ES2664818T3 (https=)
HK (1) HK1052872A1 (https=)
IL (2) IL151314A0 (https=)
WO (1) WO2001060382A1 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030130212A1 (en) * 1999-01-14 2003-07-10 Rossignol Daniel P. Administration of an anti-endotoxin drug by intravenous infusion
AU2001238507C9 (en) * 2000-02-18 2005-07-07 Eisai R&D Management Co., Ltd. Micelles
US7759323B2 (en) * 2001-05-22 2010-07-20 Eisai R & D Management Co., Ltd. Highly purified antiendotoxin compound
US7727974B2 (en) 2001-08-10 2010-06-01 Eisai R & D Management Co., Ltd. Methods of reducing the severity of mucositis
EP1420798A4 (en) * 2001-08-10 2007-07-25 Eisai Co Ltd TREATMENT AND PREVENTION OF DISEASES AND CONDITIONS RELATED TO HEAT SHOCK PROTEIN
US20040005351A1 (en) * 2002-03-29 2004-01-08 Kwon Glen S. Polymeric micelle formulations of hydrophobic compounds and methods
US20040116360A1 (en) * 2002-10-15 2004-06-17 Kwon Glen S. Encapsulation and deaggregation of polyene antibiotics using poly(ethylene glycol)-phospholipid micelles
EP1661556A4 (en) * 2003-08-20 2010-05-19 Ajinomoto Kk MEDICAL PREPARATION WITH IMPROVED RESOLUTION CHARACTERISTICS
ATE446581T1 (de) * 2004-03-12 2009-11-15 Trinity College Dublin Magnetoresistives medium
CA2620027A1 (en) * 2005-08-31 2007-03-08 Eisai R & D Management Co., Ltd. Process for production of lipid a analogue
US20070197486A1 (en) * 2005-12-20 2007-08-23 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids
US20070160542A1 (en) * 2005-12-20 2007-07-12 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile
US20070249572A1 (en) * 2005-12-20 2007-10-25 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids
US20070178049A1 (en) * 2005-12-20 2007-08-02 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile
US20070185066A1 (en) * 2005-12-20 2007-08-09 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids
JP2009526858A (ja) * 2006-02-15 2009-07-23 ティカ レーケメデル アーベー コルチコステロイド溶液を製造する方法
BR112014024139A8 (pt) 2012-03-28 2018-01-16 Univ Maryland administração de eritoran ou sais farmaceuticamente aceitáveis do mesmo para tratar infecções de ortomixovírus
JP7069120B2 (ja) 2016-09-16 2022-05-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 エボラ(ebola)及びマールブルク(marburg)病を治療するためのtlr4拮抗薬としてのエリトランの使用方法
US10765633B2 (en) 2018-12-17 2020-09-08 Eisai R&D Management Co., Ltd Formulation comprising liposomes
US11198831B2 (en) 2019-01-31 2021-12-14 Kvi Llc Lubricant for a device
WO2021207218A1 (en) 2020-04-06 2021-10-14 Eisai R&D Management Co., Ltd. Treatment of nidovirales infection with eritoran

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530113A (en) 1991-10-11 1996-06-25 Eisai Co., Ltd. Anti-endotoxin compounds
US6417172B1 (en) 1995-06-05 2002-07-09 Eisai Co., Ltd. Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs
US5681824A (en) 1995-06-05 1997-10-28 Eisai Co., Ltd. Substituted liposaccharides useful in the treatment and prevention of endotoxemia
US5952309A (en) * 1995-09-29 1999-09-14 Eisai Company, Ltd. Method for treating alcoholic liver disease
DK0909562T3 (da) * 1996-07-03 2005-08-22 Eisai Co Ltd Injektionspræparat indeholdende en lipid A analog og fremgangsmåde til fremstilling deraf
JP4326030B2 (ja) * 1996-07-03 2009-09-02 エーザイ・アール・アンド・ディー・マネジメント株式会社 リピッドa類縁体含有注射用製剤及びその製造方法
US6495532B1 (en) 1997-03-19 2002-12-17 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
AU7799198A (en) 1997-05-23 1998-12-21 Eisai Co. Ltd. Method for preparing pharmaceutical formulation
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
AU2001229479A1 (en) 2000-01-14 2001-07-24 Eisai Co. Ltd. Prevention and treatment of endotoxemia and related complications associated with surgery
AU2001238507C9 (en) * 2000-02-18 2005-07-07 Eisai R&D Management Co., Ltd. Micelles
US6861512B2 (en) 2000-03-01 2005-03-01 Eisai Co., Ltd. Separation of olefinic isomers
US20030105033A1 (en) 2000-06-09 2003-06-05 Rossignol Daniel P. Administration of an anti-endotoxin drug by bolus or intermittent intravenous infusion
JP4179881B2 (ja) 2000-12-06 2008-11-12 エーザイ株式会社 凍結乾燥ケークの抵抗を測定するためのシステム及び方法
CA2446356C (en) 2001-05-09 2012-07-10 The Regents Of The University Of Michigan Use of compositions for treating rosacea
US7727974B2 (en) 2001-08-10 2010-06-01 Eisai R & D Management Co., Ltd. Methods of reducing the severity of mucositis
BRPI0408077A (pt) 2003-03-05 2006-02-14 Eisai Co Ltd composições e métodos para prevenção e tratamento de doenças relacionadas com endotoxina e condições

Similar Documents

Publication Publication Date Title
JP2003522797A5 (https=)
US7989432B2 (en) Micelles
JP2000500160A (ja) 非水性結腸下剤処方物
KR101052705B1 (ko) 아미노글리코시드계 항생물질 및 브롬페낙을 함유하는수용액 제제
JP2010503731A5 (https=)
EP3808354A1 (en) Solid preparation composition for oral administration of colonic purgative containing anhydrous sodium sulfate, potassium sulfate, anhydrous magnesium sulfate and simethicone
EP0191792B1 (de) Prostacyclin-derivate mit zytoprotektiver wirkung an der niere
JP3040463B2 (ja) 抗血栓症作用を有する組合せ調剤
TWI422368B (zh) 治療慢性阻塞性肺疾之組成物
WO2008066783A2 (en) Therapeutic materials and methods
KR940703840A (ko) 치환 벤즈이미다졸, 그의 제조 방법 및 용도(substituted benzimidazoles, process for their preparation as well as their use)
DE4104607A1 (de) Prostacyclin- und carbacyclinderivate als mittel zur behandlung von fiebrigen erkrankungen
JP2021521268A5 (https=)
TW201500042A (zh) 與血液透析有關的低血壓的治療
AU2010296307B2 (en) Pharmaceutical combination for treating tumor
AU2002338038B2 (en) Aqueous ecabet sodium solution preparation
US20160271097A1 (en) Formulation of olopatadine
JP2000191537A (ja) 炎症性呼吸器疾患治療剤
HK40044330A (en) Solid preparation composition for oral administration of colonic purgative containing anhydrous sodium sulfate, potassium sulfate, anhydrous magnesium sulfate and simethicone
EP0761225A1 (en) Pharmaceutical composition for treating peripheral circulation disorder
JP2013001677A (ja) 抗コリン作動薬を含む再発性多発軟骨炎を含む気管気管支軟化症の治療剤
HK1096609A1 (zh) 用於治疗胃病的含有抗溃疡药和粘膜保护剂的药物组合物
HK1096609B (en) Pharmaceutical composition for treating gastric disease containing antiulcerent and mucosal protective agents
CA2385746A1 (en) Method